Numerai GP LLC: LOB position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Numerai GP LLC on LOB, newest first. How the timeline and the estimate are built.
Numerai GP LLC held 0 LOB shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 0 sharesChange vs previous 13F -48,305 shares
13F-HR 0001214659-26-010378 filed by Numerai GP LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2026-03-3113F 48,305 sharesChange vs previous 13F -19,573 shares
0.16% of the 13F portfolio, value $1,597,446.
13F-HR 0001214659-26-006464 filed by Numerai GP LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 67,878 sharesChange vs previous 13F +226 shares
0.28% of the 13F portfolio, value $2,331,609.
13F-HR 0001214659-26-001975 filed by Numerai GP LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 67,652 sharesChange vs previous 13F -107,371 shares
0.34% of the 13F portfolio, value $2,382,703.
13F-HR 0001214659-25-016630 filed by Numerai GP LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 175,023 sharesChange vs previous 13F +110,950 shares
0.75% of the 13F portfolio, value $5,215,685.
13F-HR 0001214659-25-012224 filed by Numerai GP LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 64,073 sharesChange vs previous 13F not available
0.32% of the 13F portfolio, value $1,708,186.
13F-HR 0001214659-25-007830 filed by Numerai GP LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).